Givlaari Approved for Acute Hepatic Porphyria

FRIDAY, Nov. 22, 2019 -- On Wednesday, the U.S. Food and Drug Administration announced the approval of Givlaari (givosiran) for the treatment of acute hepatic porphyria. Previous treatment options for this genetic disorder have only provided partial...
Source: Drugs.com - Daily MedNews - Category: General Medicine Source Type: news